Synthesis and PET imaging studies of [18F]2-fluoroquinolin-8-ol ([18F]CABS13) in transgenic mouse models of Alzheimer's diseaseElectronic supplementary information (ESI) available: Experimental details for synthesis and characterization of [18F]1, 1-4, 4-halo-hydroxyquinoline derivatives, as well as in vitro, immunohistochemistry, and imaging studies. See DOI: 10.1039/c2md20075a
Benzyloxy-2-chloroquinoline was reacted with fluorine-18 labelled potassium cryptand fluoride, followed by catalytic hydrogenation to prepare [ 18 F]2-fluoroquinolin-8-ol in high radiochemical yields (30%; uncorrected and relative to [ 18 F]-fluoride), specific activities (>1 Ci μmol −1 ) and rad...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Journal Article |
Language | English |
Published |
26.09.2012
|
Online Access | Get full text |
Cover
Loading…
Summary: | Benzyloxy-2-chloroquinoline was reacted with fluorine-18 labelled potassium cryptand fluoride, followed by catalytic hydrogenation to prepare [
18
F]2-fluoroquinolin-8-ol in high radiochemical yields (30%; uncorrected and relative to [
18
F]-fluoride), specific activities (>1 Ci μmol
−1
) and radiochemical purities (>99%) within 70 min; PET-CT imaging with this new radiotracer in double transgenic mice shows excellent promise for imaging Alzheimer's disease.
PET-CT imaging with [
18
F]2-fluoroquinolin-8-ol in double transgenic mice shows excellent promise for imaging Alzheimer's disease. |
---|---|
Bibliography: | immunohistochemistry, and imaging studies. See DOI 1 10.1039/c2md20075a F in vitro 18 1-4 4-halo-hydroxyquinoline derivatives, as well as , Electronic supplementary information (ESI) available: Experimental details for synthesis and characterization of |
ISSN: | 2040-2503 2040-2511 |
DOI: | 10.1039/c2md20075a |